• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性李-佛美尼综合征中 TP53 基因胚系 p.R181H 变异与基因型-表型相关性的实例

Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome.

机构信息

Department of Pediatrics, Division of Hematology-Oncology, Montreal Children's Hospital, McGill University Health Centre, Montreal, QC, Canada.

Department of Child Health and Human Development, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.

出版信息

Fam Cancer. 2024 Nov;23(4):665-669. doi: 10.1007/s10689-024-00419-7. Epub 2024 Sep 11.

DOI:10.1007/s10689-024-00419-7
PMID:39261343
Abstract

Li-Fraumeni syndrome (LFS) is a cancer predisposition syndrome associated with germline pathogenic/likely pathogenic variants in TP53. Genotype-phenotype correlations are progressively being characterized in LFS with certain TP53 variants associated with attenuated penetrance and phenotypes. We report on a family harboring a TP53 p.R181H variant presenting with a restricted cancer phenotype in adulthood. The proband was a female with breast cancer at the age of 71 years who had three first degree relatives also diagnosed with breast cancer after the age of 40 years (mother, two sisters). Of the nine individuals harboring the variant (6 genetically confirmed, 3 obligate heterozygous), six have not developed malignancies at this time (age range: 36-42). No childhood-onset cancers were reported in this family. A concomitant literature review identified 51 additional individuals harboring the p.R181H variant in TP53, presenting a tumor phenotype dominated by breast cancer. Rare occurrences of other adult-onset cancers (prostate, colorectal and thyroid) and only few childhood onset cancer were documented. These observations are consistent with functional analysis showing that p.R181H retains partial p53 function and suggesting possible reduced cancer penetrance, particularly in the pediatric setting.

摘要

李-佛美尼综合征(Li-Fraumeni syndrome,LFS)是一种与 TP53 种系致病性/可能致病性变异相关的癌症易感性综合征。随着特定 TP53 变异与减弱的外显率和表型相关的关系逐渐被确定,LFS 的基因型-表型相关性也在逐步得到描绘。我们报告了一个携带 TP53 p.R181H 变异的家族,该家族在成年期表现出受限的癌症表型。先证者为一名 71 岁的女性,患有乳腺癌,她有 3 位一级亲属也在 40 岁后被诊断出患有乳腺癌(母亲、2 位姐妹)。在携带该变异的 9 个人中(6 人经基因确认,3 人为必然杂合子),目前有 6 人尚未发生恶性肿瘤(年龄范围:36-42 岁)。该家族没有报告儿童期癌症。同时进行的文献复习确定了 51 例携带 TP53 p.R181H 变异的额外个体,其肿瘤表型以乳腺癌为主。罕见的其他成人发病的癌症(前列腺癌、结直肠癌和甲状腺癌)和极少数儿童期发病的癌症也有报道。这些观察结果与功能分析一致,表明 p.R181H 保留了部分 p53 功能,并提示可能降低了癌症的外显率,特别是在儿科环境中。

相似文献

1
Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome.家族性李-佛美尼综合征中 TP53 基因胚系 p.R181H 变异与基因型-表型相关性的实例
Fam Cancer. 2024 Nov;23(4):665-669. doi: 10.1007/s10689-024-00419-7. Epub 2024 Sep 11.
2
Li-Fraumeni syndrome in Tunisian carriers with different and rare tumor phenotype: genotype-phenotype correlation.Li-Fraumeni 综合征在具有不同和罕见肿瘤表型的突尼斯携带者中的表现:基因型-表型相关性。
BMC Med Genomics. 2022 Mar 4;15(1):44. doi: 10.1186/s12920-022-01189-w.
3
Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study.携致病性或疑似致病性种系 TP53 变异个体的癌症发病情况、模式及基因型-表型相关性:一项观察性队列研究。
Lancet Oncol. 2021 Dec;22(12):1787-1798. doi: 10.1016/S1470-2045(21)00580-5. Epub 2021 Nov 12.
4
Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis.基于国际胚系 TP53 变异数据集中的 Li-Fraumeni 谱分析:国际癌症研究机构 TP53 数据库分析。
JAMA Oncol. 2021 Dec 1;7(12):1800-1805. doi: 10.1001/jamaoncol.2021.4398.
5
Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.2019 年 1.1 版李-佛美尼综合征医学指南
Int J Clin Oncol. 2021 Dec;26(12):2161-2178. doi: 10.1007/s10147-021-02011-w. Epub 2021 Oct 11.
6
Identification and Management of Gene Carriers Detected Through Multigene Panel Testing.通过多基因检测面板检测到的基因携带者的识别与管理。
South Med J. 2017 Oct;110(10):643-648. doi: 10.14423/SMJ.0000000000000711.
7
TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.李-佛美尼综合征及类李-佛美尼综合征家族中的TP53和CDKN1A突变分析
Fam Cancer. 2017 Apr;16(2):243-248. doi: 10.1007/s10689-016-9935-z.
8
The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer.TP53 致病性变异在早发性 HER2 阳性乳腺癌中的作用。
Fam Cancer. 2021 Jul;20(3):173-180. doi: 10.1007/s10689-020-00212-2. Epub 2020 Oct 14.
9
Characterisation of heritable TP53-related cancer syndrome in Sweden-a nationwide study of genotype-phenotype correlations in 90 families.瑞典遗传性TP53相关癌症综合征的特征分析——一项对90个家庭基因型-表型相关性的全国性研究
Eur J Hum Genet. 2025 Apr;33(4):513-522. doi: 10.1038/s41431-024-01753-1. Epub 2025 Jan 5.
10
Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.《结肠癌家族登记处早发性结直肠癌患者的胚系 TP53 突变》
JAMA Oncol. 2015 May;1(2):214-21. doi: 10.1001/jamaoncol.2015.0197.

本文引用的文献

1
Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variants.基于全基因组的方法研究致病性或可能致病性种系 TP53 变异体的流行情况和癌症表型。
HGG Adv. 2024 Jan 11;5(1):100242. doi: 10.1016/j.xhgg.2023.100242. Epub 2023 Sep 29.
2
Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis.基于国际胚系 TP53 变异数据集中的 Li-Fraumeni 谱分析:国际癌症研究机构 TP53 数据库分析。
JAMA Oncol. 2021 Dec 1;7(12):1800-1805. doi: 10.1001/jamaoncol.2021.4398.
3
Comprehensive assessment of TP53 loss of function using multiple combinatorial mutagenesis libraries.
利用多个组合诱变文库对 TP53 功能丧失进行综合评估。
Sci Rep. 2020 Nov 23;10(1):20368. doi: 10.1038/s41598-020-74892-2.
4
Genotype-phenotype correlations among TP53 carriers: Literature review and analysis of probands undergoing multi-gene panel testing and single-gene testing.TP53基因携带者的基因型-表型相关性:文献综述以及对接受多基因检测和单基因检测的先证者的分析
Cancer Genet. 2020 Oct;248-249:11-17. doi: 10.1016/j.cancergen.2020.09.002. Epub 2020 Sep 11.
5
What 20 years of research has taught us about the TP53 p.R337H mutation.20 年研究揭示 TP53 p.R337H 突变的奥秘。
Cancer. 2020 Nov 1;126(21):4678-4686. doi: 10.1002/cncr.33143. Epub 2020 Aug 17.
6
UKCGG Consensus Group guidelines for the management of patients with constitutional pathogenic variants.英国临床基因组学联盟(UKCGG)关于携带遗传性致病变异患者管理的共识小组指南
J Med Genet. 2020 Jun 22;58(2):135-9. doi: 10.1136/jmedgenet-2020-106876.
7
Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes.Li-Fraumeni 及可遗传性 TP53 相关癌症综合征指南。
Eur J Hum Genet. 2020 Oct;28(10):1379-1386. doi: 10.1038/s41431-020-0638-4. Epub 2020 May 26.
8
Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome.重新审视种系TP53突变携带者的肿瘤模式和外显率:李-弗劳梅尼综合征的时间阶段
Curr Opin Oncol. 2018 Jan;30(1):23-29. doi: 10.1097/CCO.0000000000000423.
9
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.Li-Fraumeni 综合征患者的癌症筛查建议。
Clin Cancer Res. 2017 Jun 1;23(11):e38-e45. doi: 10.1158/1078-0432.CCR-17-0408.
10
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.重新审视携 TP53 突变者的李-佛美尼综合征。
J Clin Oncol. 2015 Jul 20;33(21):2345-52. doi: 10.1200/JCO.2014.59.5728. Epub 2015 May 26.